Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea flag South Korea · Delayed Price · Currency is KRW
35,650
+2,050 (6.10%)
Apr 1, 2025, 3:30 PM KST

Mezzion Pharma Revenue

In the year 2024, Mezzion Pharma had annual revenue of 8.61B KRW, down -72.85%. Mezzion Pharma had revenue of 1.92B in the quarter ending December 31, 2024, a decrease of -73.96%.

Revenue
8.61B
Revenue Growth
-72.85%
P/S Ratio
123.47
Revenue / Employee
506.57M
Employees
17
Market Cap
1,068.19B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20248.61B-23.11B-72.85%
Dec 31, 202331.72B994.76M3.24%
Dec 31, 202230.73B4.07B15.28%
Dec 31, 202126.65B-1.98B-6.92%
Dec 31, 202028.63B10.71B59.79%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 300.87T
SK hynix 66.19T
LG Energy Solution 25.62T
Samsung Biologics 4,547.32B
Hyundai Motor Company 175.23T
Celltrion 3,557.30B
Kia Corporation 107.45T
KB Financial Group 15.01T
Revenue Rankings